1. A novel F420‐dependent anti‐oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents. Issue 4 (28th December 2012) Authors: Gurumurthy, Meera; Rao, Martin; Mukherjee, Tathagata; Rao, Srinivasa P. S.; Boshoff, Helena I.; Dick, Thomas; Barry, Clifton E.; Manjunatha, Ujjini H. Journal: Molecular microbiology Issue: Volume 87:Issue 4(2013) Page Start: 744 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial. Issue 2 (February 2023) Authors: Rosu, Laura; Madan, Jason J; Tomeny, Ewan M; Muniyandi, Malaisamy; Nidoi, Jasper; Girma, Mamo; Vilc, Valentina; Bindroo, Priyanka; Dhandhukiya, Rajdeep; Bayissa, Adamu K; Meressa, Daniel; Narendran, Gopalan; Solanki, Rajesh; Bhatnagar, Anuj K; Tudor, Elena; Kirenga, Bruce; Meredith, Sarah K; Nunn... Journal: Lancet Issue: Volume 11:Issue 2(2023) Page Start: e265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial. Issue 10366 (26th November 2022) Authors: Goodall, Ruth L; Meredith, Sarah K; Nunn, Andrew J; Bayissa, Adamu; Bhatnagar, Anuj K; Bronson, Gay; Chiang, Chen-Yuan; Conradie, Francesca; Gurumurthy, Meera; Kirenga, Bruce; Kiria, Nana; Meressa, Daniel; Moodliar, Ronelle; Narendran, Gopalan; Ngubane, Nosipho; Rassool, Mohammed; Sanders, Karen;... Journal: Lancet Issue: Volume 400:Issue 10366(2022) Page Start: 1858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗